Block listing Interim Review

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan

Period of return:

From:

1 November 2024

To:

30 April 2025

Balance of unallotted securities under scheme(s) from previous return:

115,518

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

115,518

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2012

Period of return:

From:

1 November 2024

To:

30 April 2025

Balance of unallotted securities under scheme(s) from previous return:

517,238

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

700,000

Less:  Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G):

946,923

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

270,315

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2022

Period of return:

From:

1 November 2024

To:

30 April 2025

Balance of unallotted securities under scheme(s) from previous return:

975,390

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G):

23,599

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

951,791

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000